Spots Global Cancer Trial Database for choriocarcinoma
Every month we try and update this database with for choriocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The French National Reference Centre of GTD | NCT02892877 | Neoplasm, Troph... Gestational Tro... Hydatidiform Mo... Hydatidiform Mo... | - | Hospices Civils de Lyon | ||
Molecular Epidemiology of Pediatric Germ Cell Tumors | NCT05564026 | Germ Cell Tumor Germinoma Teratoma Embryonal Carci... Yolk Sac Tumor Choriocarcinoma Mixed Germ Cell... Late Effects Pediatric Germ ... | Questionnaire A... Tumor Specimen ... Germline DNA Sa... Blood Sample Co... | - | Children's Oncology Group | |
Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma | NCT00294177 | Trophoblastic N... Choriocarcinoma | atomic force mi... dual polarisati... | 0 Years - | National Taiwan University Hospital | |
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | NCT01535053 | Choriocarcinoma FIGO Stage I Ge... FIGO Stage II G... FIGO Stage III ... Hydatidiform Mo... | Dactinomycin Leucovorin Calc... Methotrexate Quality-of-Life... | 18 Years - | GOG Foundation | |
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours | NCT00475956 | Neoplasms | AZD2171 AZD0530 | 18 Years - | AstraZeneca | |
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) | NCT02664961 | Gestational Tro... Choriocarcinoma Placental Site ... Epithelioid Tro... | TRC105 Bevacizumab | 16 Years - 99 Years | Tracon Pharmaceuticals Inc. | |
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | NCT06418789 | Germ Cell Tumor | High-dose chemo... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | NCT06418789 | Germ Cell Tumor | High-dose chemo... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
Molecular Epidemiology of Pediatric Germ Cell Tumors | NCT05564026 | Germ Cell Tumor Germinoma Teratoma Embryonal Carci... Yolk Sac Tumor Choriocarcinoma Mixed Germ Cell... Late Effects Pediatric Germ ... | Questionnaire A... Tumor Specimen ... Germline DNA Sa... Blood Sample Co... | - | Children's Oncology Group | |
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | NCT04562558 | Gestational Tro... Gestational Tro... Stage I Gestati... Stage II Gestat... Stage III Gesta... Invasive Mole Choriocarcinoma | Methotrexate Leucovorin Dactinomycin | 18 Years - 75 Years | Peking Union Medical College Hospital | |
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT | NCT04684368 | Central Nervous... Choriocarcinoma Embryonal Carci... Immature Terato... Malignant Terat... Mixed Germ Cell... Pineal Region G... Pineal Region I... Pineal Region Y... Suprasellar Ger... | Biospecimen Col... Carboplatin Etoposide Filgrastim Ifosfamide Magnetic Resona... Mesna Pegfilgrastim Peripheral Bloo... Questionnaire A... Radiation Thera... Radiation Thera... Second-Look Sur... Thiotepa | 3 Years - 29 Years | Children's Oncology Group | |
Clinical Database and Biobank of Patients With Gynecologic Neoplasms | NCT01267851 | Cervical Cancer Ovarian Cancer Endometrial Can... Choriocarcinoma Uterine Myoma Endometriosis | 18 Years - 75 Years | Huazhong University of Science and Technology | ||
TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma | NCT02396511 | Choriocarcinoma | TRC105 Bevacizumab | 18 Years - | Tracon Pharmaceuticals Inc. |